Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

References for PMC Articles for PubMed (Select 19396626)

1.

A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.

Ramalingam SS, Egorin MJ, Ramanathan RK, Remick SC, Sikorski RP, Lagattuta TF, Chatta GS, Friedland DM, Stoller RG, Potter DM, Ivy SP, Belani CP.

Clin Cancer Res. 2008 Jun 1;14(11):3456-61. doi: 10.1158/1078-0432.CCR-07-5088.

2.

The human TPR protein TTC4 is a putative Hsp90 co-chaperone which interacts with CDC6 and shows alterations in transformed cells.

Crevel G, Bennett D, Cotterill S.

PLoS One. 2008 Mar 5;3(3):e0001737. doi: 10.1371/journal.pone.0001737.

3.

The Hsp90 molecular chaperone: an open and shut case for treatment.

Pearl LH, Prodromou C, Workman P.

Biochem J. 2008 Mar 15;410(3):439-53. doi: 10.1042/BJ20071640. Review.

PMID:
18290764
4.

GCUNC45 is the first Hsp90 co-chaperone to show alpha/beta isoform specificity.

Chadli A, Felts SJ, Toft DO.

J Biol Chem. 2008 Apr 11;283(15):9509-12. doi: 10.1074/jbc.C800017200. Epub 2008 Feb 19.

5.

A novel HSP90 chaperone complex regulates intracellular vesicle transport.

Lotz GP, Brychzy A, Heinz S, Obermann WM.

J Cell Sci. 2008 Mar 1;121(Pt 5):717-23. doi: 10.1242/jcs.015610. Epub 2008 Feb 12.

6.

Molecular chaperone Hsp90 stabilizes Pih1/Nop17 to maintain R2TP complex activity that regulates snoRNA accumulation.

Zhao R, Kakihara Y, Gribun A, Huen J, Yang G, Khanna M, Costanzo M, Brost RL, Boone C, Hughes TR, Yip CM, Houry WA.

J Cell Biol. 2008 Feb 11;180(3):563-78. doi: 10.1083/jcb.200709061.

7.

Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study.

Modi S, Stopeck AT, Gordon MS, Mendelson D, Solit DB, Bagatell R, Ma W, Wheler J, Rosen N, Norton L, Cropp GF, Johnson RG, Hannah AL, Hudis CA.

J Clin Oncol. 2007 Dec 1;25(34):5410-7.

8.

Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches.

McClellan AJ, Xia Y, Deutschbauer AM, Davis RW, Gerstein M, Frydman J.

Cell. 2007 Oct 5;131(1):121-35.

9.

The tetratricopeptide repeats of receptors involved in protein translocation across membranes.

Schlegel T, Mirus O, von Haeseler A, Schleiff E.

Mol Biol Evol. 2007 Dec;24(12):2763-74. Epub 2007 Sep 28.

10.

Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.

Schumacher JA, Crockett DK, Elenitoba-Johnson KS, Lim MS.

Proteomics. 2007 Aug;7(15):2603-16.

PMID:
17610208
11.

Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer.

Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, Mimori K, Tanaka F, Watanabe M, Mori M.

Ann Surg Oncol. 2007 Sep;14(9):2543-9. Epub 2007 Jun 28.

PMID:
17597343
12.

Novel subunits of the mammalian Hsp90 signal transduction chaperone.

Te J, Jia L, Rogers J, Miller A, Hartson SD.

J Proteome Res. 2007 May;6(5):1963-73. Epub 2007 Mar 10.

PMID:
17348703
13.

Molecular chaperones and protein kinase quality control.

Caplan AJ, Mandal AK, Theodoraki MA.

Trends Cell Biol. 2007 Feb;17(2):87-92. Epub 2006 Dec 20. Review.

PMID:
17184992
14.

Structural Analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements.

Shiau AK, Harris SF, Southworth DR, Agard DA.

Cell. 2006 Oct 20;127(2):329-40.

15.

Hsp90 functions in the targeting and outer membrane translocation steps of Tom70-mediated mitochondrial import.

Fan AC, Bhangoo MK, Young JC.

J Biol Chem. 2006 Nov 3;281(44):33313-24. Epub 2006 Sep 12.

16.

Structure of an Hsp90-Cdc37-Cdk4 complex.

Vaughan CK, Gohlke U, Sobott F, Good VM, Ali MM, Prodromou C, Robinson CV, Saibil HR, Pearl LH.

Mol Cell. 2006 Sep 1;23(5):697-707.

17.

Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy.

Weinstein IB, Joe AK.

Nat Clin Pract Oncol. 2006 Aug;3(8):448-57. Review.

PMID:
16894390
18.

Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex.

Ali MM, Roe SM, Vaughan CK, Meyer P, Panaretou B, Piper PW, Prodromou C, Pearl LH.

Nature. 2006 Apr 20;440(7087):1013-7.

PMID:
16625188
19.

Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases.

Terasawa K, Yoshimatsu K, Iemura S, Natsume T, Tanaka K, Minami Y.

Mol Cell Biol. 2006 May;26(9):3378-89.

20.

Hsp90 recognizes a common surface on client kinases.

Citri A, Harari D, Shohat G, Ramakrishnan P, Gan J, Lavi S, Eisenstein M, Kimchi A, Wallach D, Pietrokovski S, Yarden Y.

J Biol Chem. 2006 May 19;281(20):14361-9. Epub 2006 Mar 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk